Neurodegenerative disease and iron storage in the brain

被引:93
|
作者
Thomas, M
Jankovic, J
机构
[1] Baylor Coll Med, Dept Neurol, Parkinsons Dis Ctr & Movement Disorders Clin, Houston, TX 77030 USA
[2] NINDS, Expt Therapeut Branch, Clin Pharmacol Sect, NIH, Bethesda, MD USA
关键词
Hallervorden-Spatz; iron in the brain; neurodegeneration; neuroferritinopathy; parkinsonism;
D O I
10.1097/01.wco.0000137534.61244.d1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Iron is very important for normal regulation of various metabolic pathways. Neurons store iron in the form of ferrous ion or neuromelanin. In specific disorders the axonal transport of iron is impaired, leading to iron deposition which in the presence of reactive oxygen species results in neurodegeneration. Recent findings Recent developments in genetics, including the finding of mutations in the pantothenate kinase gene and ferritin light chain gene, have demonstrated a direct relationship between the presence of a mutation in the iron-regulatory pathways and iron deposition in the brain resulting in neurodegeneration. These two disorders now add to our understanding of the mechanism of disease due to dysfunction of iron-regulatory pathways. In addition to these disorders there may be several other mutations of iron-regulatory genes or related genes that are yet to be found. The animal models of disease have also added value to this area. Summary In this review we provide a summary of recent developments in the field of movement disorders with abnormalities in iron transport, and the current evidence in neurodegenerative disorders such as Parkinson's disease.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 50 条
  • [1] Brain iron homeostasis and neurodegenerative disease
    Benarroch, Eduardo E.
    [J]. NEUROLOGY, 2009, 72 (16) : 1436 - 1440
  • [2] The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease
    Daglas, Maria
    Adlard, Paul A.
    [J]. FRONTIERS IN NEUROSCIENCE, 2018, 12
  • [3] INVESTIGATION OF THE CAUSAL RELATIONSHIP BETWEEN IRON ACCUMULATION IN THE BRAIN AND NEURODEGENERATIVE DISEASE
    Lupton, Michelle
    Gerring, Zachary
    Derks, Eske
    MacGregor, Stuart
    Ong, Jue-Sheng
    Fripp, Jurgen
    Raniga, Parnesh
    Fazlollahi, Amir
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : E207 - E208
  • [4] Iron, brain ageing and neurodegenerative disorders
    Zecca, L
    Youdim, MBH
    Riederer, P
    Connor, JR
    Crichton, RR
    [J]. NATURE REVIEWS NEUROSCIENCE, 2004, 5 (11) : 863 - 873
  • [5] Brain iron metabolism and neurodegenerative disorders
    Sipe, JC
    Lee, P
    Beutler, E
    [J]. DEVELOPMENTAL NEUROSCIENCE, 2002, 24 (2-3) : 188 - 196
  • [6] Iron, brain ageing and neurodegenerative disorders
    Luigi Zecca
    Moussa B. H. Youdim
    Peter Riederer
    James R. Connor
    Robert R. Crichton
    [J]. Nature Reviews Neuroscience, 2004, 5 : 863 - 873
  • [7] The role of labile iron on brain proteostasis; could it be an early event of neurodegenerative disease?
    Kittilukkana, Aiyarin
    Intakhad, Jannarong
    Pilapong, Chalermchai
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 756
  • [8] Neurodegenerative disease - Ataxin the brain
    Brazil, M
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) : 508 - 509
  • [9] Aging, neurodegenerative disease and the brain
    McGeer, EG
    McGeer, PL
    [J]. CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT, 1997, 16 (02): : 218 - 236
  • [10] Neurodegenerative disease: brain windfall
    Gammon K.
    [J]. Nature, 2014, 515 (7526) : 299 - 300